文献

J-GLOBAL ID：201202231608185126   整理番号：12A0823025

プロリルカルボキシペプチターゼ抑制剤の新しいクラス、パート1:発見および評価

A new class of prolylcarboxypeptidase inhibitors, Part 1: Discovery and evaluation

著者 (25件)： GRAHAM Thomas H. (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  LIU Wensheng (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  VERRAS Andreas (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  SEBHAT Iyassu K. (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  XIONG Yusheng (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  BLEASBY Kelly (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  BHATT Urmi R. (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  CHEN Qing (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  GARCIA-CALVO Margarita (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  GEISSLER Wayne M. (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  GORSKI Judith N. (Dep. of In Vivo Pharmacology, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  HE Huaibing (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  LASSMAN Michael E. (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  LISNOCK Jeanmarie (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  LI Xiaohua (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  SHEN Zhu (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  TONG Xinchun (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  TUNG Elaine C. (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  WILTSIE Judyann (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  XIAO Jianying (Dep. of In Vivo Pharmacology, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  XIE Dan (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  XU Suoyu (Dep. of Drug Metabolism, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  HALE Jeffrey J. (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  PINTO Shirly (Dep. of Metabolic Disorders, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA) ,  SHEN Dong-ming (Dep. of Medicinal Chemistry, Merck Res. Laboratories, PO Box 2000, Rahway, NJ 07065-0900, USA)
資料名： Bioorganic & Medicinal Chemistry Letters  (Bioorganic & Medicinal Chemistry Letters)
巻： 22  号： 8  ページ： 2811-2817  発行年： 2012年04月15日 
JST資料番号： W0248A  ISSN： 0960-894X  資料種別： 逐次刊行物 (A)
発行国： オランダ (NLD)  言語： 英語 (EN)

タイトルに関連する用語 (5件)： 抑制剤 ,  クラス ,  パート ,  発見 ,  評価